The extraordinary success of mRNA vaccines against coronavirus disease 2019 (COVID-19)
has renewed interest in mRNA as a means of delivering therapeutic proteins. Early clinical …

Regenerative medicine is a new and promising mode of therapy for patients who have
limited or no other options for the treatment of their illness. Due to their pleotropic therapeutic …

Cardiovascular disease is a leading cause of death worldwide, and thus there remains great
interest in regenerative approaches to treat heart failure. In the past 20 years, the field of …

Extracellular vesicles (EVs) are a heterogeneous population of lipid bilayer membrane-
bound vesicles which encapsulate bioactive molecules, such as nucleic acids, proteins, and …

Myocardial infarction (MI) is one of the typical cardiovascular diseases, which persist as the
leading cause of death globally. Due to the poor regenerative capability of endogenous …

Adoptive cell therapy (ACT) is a rapidly growing anti‐cancer strategy that has shown
promise in treating various cancer types. The concept of ACT involves activating patients' …

Adipose tissue-derived stromal cells (ASCs) are of interest in tissue engineering and
regenerative medicine (TERM) due to their easy acquisition, multipotency, and secretion of a …

Cardiovascular disease is the leading cause of death in the world. Stem cell-based
therapies have been widely investigated for cardiac regeneration in patients with heart …

Aims: The invasive intramyocardial injection of mesenchymal stromal cells (MSCs) allows for
limited repeat injections and shows poor therapeutic efficacy against ischemic heart failure …

Gelatin methacrylate (GelMA) hydrogels have been widely used in various biomedical
applications, especially in tissue engineering and regenerative medicine, for their excellent …